Un-Audited Financial Results for the Quarter ended 30.06.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bandaram Pharma Packtech Ltd reported its Q1 FY26 results on August 14, 2025. On a standalone basis, revenue from operations fell sharply to Rs. 75.74 lakhs from Rs. 272.15 lakhs in the same quarter last year, a drop of around 72%. The company posted a standalone net loss of Rs. 26.85 lakhs (EPS of Rs. -0.22), slightly wider than the Rs. 24.86 lakh loss a year ago. On a consolidated basis, revenue declined to Rs. 810.37 lakhs from Rs. 1,136.63 lakhs, while net profit dropped to Rs. 2.47 lakhs from Rs. 17.83 lakhs. Most of the consolidated performance came from subsidiary VSR Paper and Packaging Ltd (55% owned), which contributed Rs. 799.79 lakhs in revenue and Rs. 23.82 lakhs in net profit. The statutory auditor issued an unqualified limited review report.
Standalone business continues to shrink with a widening loss, though the consolidated picture is cushioned by the packaging subsidiary. Short-term stock sentiment may remain weak given the steep standalone revenue fall and continued losses at the parent level.